vTv Therapeutics (VTVT) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChart

vTv Therapeutics Revenue Highlights


00

vTv Therapeutics Revenue by Period


vTv Therapeutics Revenue by Year

DateRevenueChange
2023-12-31--100.00%
2022-12-31$2.02M-49.61%
2021-12-31$4.00M-37.56%
2020-12-31$6.41M132.05%
2019-12-31$2.76M-77.77%
2018-12-31$12.43M4172.85%
2017-12-31$291.00K-54.10%
2016-12-31$634.00K22.16%
2015-12-31$519.00K-66.49%
2014-12-31$1.55M58.71%
2013-12-31$976.00K-

vTv Therapeutics generated - in revenue during NA 2023, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

vTv Therapeutics Revenue by Quarter

DateRevenueChange
2024-06-30--100.00%
2024-03-31$1.00M-11211.11%
2023-12-31$-9.00K100.00%
2023-09-30--100.00%
2023-06-30$9.00K100.00%
2023-03-31--100.00%
2022-12-31$9.00K100.00%
2022-09-30--100.00%
2022-06-30$9.00K-99.55%
2022-03-31$2.00M22122.22%
2021-12-31$9.00K-99.70%
2021-09-30$3.00M33233.33%
2021-06-30$9.00K-99.09%
2021-03-31$987.00K-84.58%
2020-12-31$6.40M91314.29%
2020-09-30$7.00K100.00%
2020-06-30--100.00%
2020-03-31$8.00K14.29%
2019-12-31$7.00K-12.50%
2019-09-30$8.00K-99.56%
2019-06-30$1.83M98.48%
2019-03-31$921.00K-79.63%
2018-12-31$4.52M33.99%
2018-09-30$3.38M36.47%
2018-06-30$2.47M19.82%
2018-03-31$2.06M785.84%
2017-12-31$233.00K1453.33%
2017-09-30$15.00K15.38%
2017-06-30$13.00K-56.67%
2017-03-31$30.00K-21.05%
2016-12-31$38.00K-
2016-09-30$38.00K-79.12%
2016-06-30$182.00K-51.60%
2016-03-31$376.00K66.37%
2015-12-31$226.00K69.92%
2015-09-30$133.00K20.91%
2015-06-30$110.00K120.00%
2015-03-31$50.00K-94.65%
2014-12-31$934.00K133.50%
2014-09-30$400.00K99.00%
2014-06-30$201.00K1335.71%
2014-03-31$14.00K-

vTv Therapeutics generated - in revenue during Q2 2024, up -100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

vTv Therapeutics Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
INMInMed Pharmaceuticals$6.56B$2.06B
SGTXSigilon Therapeutics$12.94M$5.90M
KRONKronos Bio$6.29M$2.69M
GBIOGeneration Bio$5.90M$4.06M
VRAXVirax Biolabs Group$8.56K$76.50K
NRBONeuroBo Pharmaceuticals$7.00K-
CCCCC4 Therapeutics--
CYTOAltamira Therapeutics-$52.73K
ZURAZura Bio--
ELEVElevation Oncology--
HILSTharimmune--
ERASErasca--
GOVXGeoVax Labs--
PYXSPyxis Oncology--
PHIOPhio Pharmaceuticals--
IMMXImmix Biopharma--
ALLRAllarity Therapeutics--
EWTXEdgewise Therapeutics--
VTVTvTv Therapeutics--
EFTReFFECTOR Therapeutics--
QNRXQuoin Pharmaceuticals--

VTVT Revenue FAQ


vTv Therapeutics's yearly revenue for 2023 was $0, representing a decrease of -100.00% compared to 2022. The company's yearly revenue for 2022 was $2.02M, representing a decrease of -49.61% compared to 2021. VTVT's yearly revenue for 2021 was $4M, representing a decrease of -37.56% compared to 2020.

vTv Therapeutics's quarterly revenue for Q2 2024 was $0, a -100.00% decrease from the previous quarter (Q1 2024), and a -100.00% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $1M, a -11211.11% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). VTVT's quarterly revenue for Q4 2023 was $-9K, a 100.00% increase from the previous quarter (Q3 2023), and a -200.00% decrease year-over-year (Q4 2022).

vTv Therapeutics's revenue growth rate for the last 3 years (2021-2023) was -100.00%, and for the last 5 years (2019-2023) was -100.00%.